Recombinant Human SSX3 protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human SSX3 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 188 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
Protein SSX3, Cancer/testis antigen 5.3, CT5.3, SSX3
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human SSX3 protein (GST tag N-Terminus) (AB160884)
ab160884 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SSX3 protein influences several cell processes by participating in gene regulation. SSX3 does not function alone but as part of protein complexes that modulate chromatin structure and accessibility. This activity affects gene transcription. SSX3 influences cellular proliferation and differentiation making it important in the development of certain tissues. The SSX3 protein’s interaction with other transcriptional regulators emphasizes its role in finely tuning gene expression.
Pathways
SSX3 plays a role in the regulation of the Wnt signaling pathway which is critical for cell proliferation and differentiation. SSX3 potentially influences this pathway through its regulatory activities on gene expression. It shares interactions with proteins like β-catenin influencing the pathway's outcome. The SSX3 protein may also interplay with the Notch signaling pathway further modulating cellular processes that guide cell fate decisions.
Specifications
Form
Liquid
General info
Function
Could act as a modulator of transcription.
Sequence similarities
Belongs to the SSX family.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com